{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Search results for tyrosine in Related Substance Name (approximate match)
Status:
Investigational
Source:
INN:adimanebart [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ruzaltatug rezetecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:trastuzumab brengitecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:izalontamab brengitecan [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Class:
PROTEIN
Status:
Investigational
Source:
INN:calotatug ginistinag [INN]
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
NCT03262935: Phase 3 Interventional Completed Metastatic Breast Cancer
(2017)
Source URL:
Class:
PROTEIN
Status:
Investigational
Source:
INN:ozuriftamab [INN]
Source URL:
Class:
PROTEIN